Literature DB >> 11700319

SKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1.

Marian R Walters1, Martin Dutertre, Carolyn L Smith.   

Abstract

The transcriptional activity of estrogen receptors (ERs) can be regulated by ligands as well as agents such as dopamine, which stimulate intracellular signaling pathways able to communicate with these receptors. We examined the ability of SKF-82958 (SKF), a previously characterized full dopamine D1 receptor agonist, to stimulate the transcriptional activity of ERalpha and ERbeta. Treatment of HeLa cells with SKF-82958 stimulated robust ERalpha-dependent transcription from an estrogen-response element-E1b-CAT reporter in the absence of estrogen, and this was accompanied by increased receptor phosphorylation. However, induction of ERbeta-directed gene expression under the same conditions was negligible. In our cell model, SKF treatment did not elevate cAMP levels nor enhance transcription from a cAMP-response element-linked reporter. Control studies revealed that SKF-82958, but not dopamine, competes with 17beta-estradiol for binding to ERalpha or ERbeta with comparable relative binding affinities. Therefore, SKF-82958 is an ERalpha-selective agonist. Transcriptional activation of ERalpha by SKF was more potent than expected from its relative binding activity, and further examination revealed that this synthetic compound induced expression of an AP-1 target gene in a tetradecanoylphorbol-13-acetate-response element (TRE)-dependent manner. A putative TRE site upstream of the estrogen-response element and the amino-terminal domain of the receptor contributed to, but were not required for, SKF-induced expression of an ERalpha-dependent reporter gene. Overexpression of the AP-1 protein c-Jun, but not c-Fos, strongly enhanced SKF-induced ERalpha target gene expression but only when the TRE was present. These studies provide information on the ability of a ligand that weakly stimulates ERalpha to yield strong stimulation of ERalpha-dependent gene expression through cross-talk with other intracellular signaling pathways producing a robust combinatorial response within the cell.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700319     DOI: 10.1074/jbc.M109320200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription.

Authors:  Xiaomei Qi; Huiying Zhi; Adrienne Lepp; Phillip Wang; Jian Huang; Zainab Basir; Christopher R Chitambar; Charles R Myers; Guan Chen
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

2.  The conundrum of estrogen receptor oscillatory activity in the search for an appropriate hormone replacement therapy.

Authors:  Sara Della Torre; Andrea Biserni; Gianpaolo Rando; Giuseppina Monteleone; Paolo Ciana; Barry Komm; Adriana Maggi
Journal:  Endocrinology       Date:  2011-04-19       Impact factor: 4.736

3.  The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.

Authors:  Theresa J Peterson; Sudipan Karmakar; Margaret C Pace; Tong Gao; Carolyn L Smith
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

4.  Marinobufagenin interferes with the function of the mineralocorticoid receptor.

Authors:  Carolyn L Smith; Qiang He; Luping Huang; Estrella Foster; Jules B Puschett
Journal:  Biochem Biophys Res Commun       Date:  2007-03-26       Impact factor: 3.575

Review 5.  Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

Authors:  Stephen Safe; Kyounghyun Kim; Kyoungkim Kim
Journal:  J Mol Endocrinol       Date:  2008-09-04       Impact factor: 5.098

6.  Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system.

Authors:  Alessandro Tozzi; Antonio de Iure; Michela Tantucci; Valentina Durante; Ana Quiroga-Varela; Carmela Giampà; Michela Di Mauro; Petra Mazzocchetti; Cinzia Costa; Massimiliano Di Filippo; Silvarosa Grassi; Vito Enrico Pettorossi; Paolo Calabresi
Journal:  Front Cell Neurosci       Date:  2015-05-27       Impact factor: 5.505

7.  Enhancing mask activity in dopaminergic neurons extends lifespan in flies.

Authors:  Xiaolin Tian
Journal:  Aging Cell       Date:  2021-10-09       Impact factor: 9.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.